The Retinoblastoma Gene

The retinoblastoma gene (RB) is a tumor suppressor gene that regulates cell division and prevents uncontrolled growth. It produces a protein that controls the cell cycle by blocking cells from progressing from the G1 phase to the S phase. When functioning normally, the RB protein acts as a brake on cell proliferation, protecting cells from becoming cancerous.

Mutations that inactivate the RB gene eliminate the cell's ability to control division, allowing cells to bypass normal growth checkpoints. Without functional RB protein, cells can progress through the cell cycle uncontrollably, leading to tumor formation. Both copies of the RB gene must be lost for retinoblastoma to develop, following the two-hit hypothesis of tumor suppression.

Hereditary retinoblastoma occurs when a person inherits one mutated RB gene copy from a parent, requiring only one additional mutation to develop cancer. Sporadic retinoblastoma develops when both RB gene mutations occur randomly in a single eye cell during a person's lifetime. Hereditary cases are often bilateral and appear earlier in childhood, while sporadic cases typically affect one eye.

Retinoblastoma develops during early childhood because retinal cells are actively dividing and differentiating during this developmental period. The rapidly dividing cells in the developing retina provide more opportunities for the two RB gene mutations to accumulate. Once children reach school age, retinal cell division slows significantly, making new tumor development much less likely.

Common signs include leukocoria, an abnormal white reflection in the pupil visible in photographs, and strabismus, or eye misalignment. Children may also experience eye pain, redness, or vision problems. Early detection through regular eye examinations is critical for preserving vision and improving treatment outcomes in affected children.

The RB gene's role as a tumor suppressor has revealed fundamental mechanisms of cell cycle control applicable to many cancer types. Research into RB dysfunction has led to targeted therapies and improved screening protocols for at-risk families. Understanding how RB mutations drive cancer development continues to inform strategies for preventing and treating various malignancies.